CARDLYTICS INC (CDLX)
US14161W1053 - Common Stock
Taking everything into account, CDLX scores 2 out of 10 in our fundamental rating. CDLX was compared to 96 industry peers in the Media industry. Both the profitability and financial health of CDLX have multiple concerns. While showing a medium growth rate, CDLX is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
CDLX had negative earnings in the past year.
CDLX had a negative operating cash flow in the past year.
CDLX had negative earnings in each of the past 5 years.
CDLX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -23.46%, CDLX is doing worse than 86.32% of the companies in the same industry.
With a Return On Equity value of -99.93%, CDLX is not doing good in the industry: 77.89% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.46% | ||
| ROE | -99.93% | ||
| ROIC | N/A |
ROA(3y)-33.65%
ROA(5y)-24.34%
ROE(3y)-112.81%
ROE(5y)-77.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 51.30%, CDLX is doing good in the industry, outperforming 65.26% of the companies in the same industry.
CDLX's Gross Margin has improved in the last couple of years.
CDLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.3% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.57%
GM growth 5Y2.94%
2. Health
2.1 Basic Checks
CDLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CDLX has been increased compared to 1 year ago.
Compared to 5 years ago, CDLX has more shares outstanding
CDLX has a worse debt/assets ratio than last year.
2.2 Solvency
CDLX has an Altman-Z score of -1.47. This is a bad value and indicates that CDLX is not financially healthy and even has some risk of bankruptcy.
CDLX has a Altman-Z score of -1.47. This is amonst the worse of the industry: CDLX underperforms 81.05% of its industry peers.
CDLX has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.91, CDLX is doing worse than 74.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.91 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.47 |
ROIC/WACCN/A
WACC7.24%
2.3 Liquidity
A Current Ratio of 1.31 indicates that CDLX should not have too much problems paying its short term obligations.
CDLX has a Current ratio of 1.31. This is in the lower half of the industry: CDLX underperforms 66.32% of its industry peers.
A Quick Ratio of 1.31 indicates that CDLX should not have too much problems paying its short term obligations.
The Quick ratio of CDLX (1.31) is worse than 66.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 81.32% over the past year.
Looking at the last year, CDLX shows a small growth in Revenue. The Revenue has grown by 3.57% in the last year.
The Revenue has been growing by 15.46% on average over the past years. This is quite good.
EPS 1Y (TTM)81.32%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q148.28%
Revenue 1Y (TTM)3.57%
Revenue growth 3Y18.27%
Revenue growth 5Y15.46%
Revenue growth Q2Q8.08%
3.2 Future
Based on estimates for the next years, CDLX will show a very strong growth in Earnings Per Share. The EPS will grow by 84.39% on average per year.
CDLX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.35% yearly.
EPS Next Y130%
EPS Next 2Y84.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.73%
Revenue Next 2Y11.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
CDLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 145.88 indicates a quite expensive valuation of CDLX.
Based on the Price/Forward Earnings ratio, CDLX is valued a bit more expensive than 63.16% of the companies in the same industry.
CDLX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 145.88 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CDLX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CDLX's earnings are expected to grow with 84.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.39%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CDLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CARDLYTICS INC
NASDAQ:CDLX (5/3/2024, 7:00:02 PM)
After market: 15 +0.12 (+0.81%)14.88
+0.91 (+6.51%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap716.77M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 145.88 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.46% | ||
| ROE | -99.93% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.3% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.91 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)81.32%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y130%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.57%
Revenue growth 3Y18.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y